Cryptococcal cellulitis in a patient with bullous pemphigoid.
Kazumitsu
K
Sugiura
Nana
N
Sugiura
Tetsuya
T
Yagi
Mitsutaka
M
Iguchi
Hideaki
H
Ohno
Yoshitsugu
Y
Miyazaki
Masashi
M
Akiyama
D000368:Aged; D000935:Antifungal Agents / Q000627:therapeutic use; D002481:Cellulitis / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology*; D003453:Cryptococcosis / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology*; D003455:Cryptococcus neoformans / Q000276:immunology / Q000302:isolation & purification*; D003881:Dermatomycoses / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology*; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D016867:Immunocompromised Host; D008172:Lung Diseases, Fungal / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology*; D008297:Male; D009894:Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology*; D010391:Pemphigoid, Bullous / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D011239:Prednisolone / Q000009:adverse effects*; D012307:Risk Factors; D012867:Skin / Q000187:drug effects / Q000473:pathology; D016896:Treatment Outcome; D034941:Upper Extremity
D000935:Antifungal Agents; D005938:Glucocorticoids; D011239:Prednisolone